 | • レポートコード：GIR-22E8825 • 出版社/出版日：GlobalInfoResearch / 2022年5月20日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| フルダラビン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のフルダラビンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 フルダラビン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・静脈内、静的ドロップ 用途別セグメントは次のように区分されます。 ・成人、子供、妊娠中／授乳中女性 世界のフルダラビン市場の主要な市場プレーヤーは以下のとおりです。 ・Sanofi、Bayer、Genzyme、Pfizer、Salius Pharma、Berlex Healthcare、Sagent Pharma、Actavis (TEVA )、Fresenius Kabi、Hospira Healthcare、Leucadia Pharmaceuticals、Mylan Institutional、Shanxi Pude Pharmaceutical、Guangdong Lingnan Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Hainan Jinrui Pharmaceutical、HISUN、Chenxin Pharmaceutical、Chongqing Laimei Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、フルダラビン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なフルダラビンメーカーの企業概要、2019年～2022年までのフルダラビンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なフルダラビンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別フルダラビンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのフルダラビンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのフルダラビン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびフルダラビンの産業チェーンを掲載しています。 ・第13、14、15章では、フルダラビンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Bayer、Genzyme、Pfizer、Salius Pharma、Berlex Healthcare、Sagent Pharma、Actavis (TEVA )、Fresenius Kabi、Hospira Healthcare、Leucadia Pharmaceuticals、Mylan Institutional、Shanxi Pude Pharmaceutical、Guangdong Lingnan Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Hainan Jinrui Pharmaceutical、HISUN、Chenxin Pharmaceutical、Chongqing Laimei Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：静脈内、静的ドロップ ・用途別分析2017年-2028年：成人、子供、妊娠中／授乳中女性 ・フルダラビンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・フルダラビンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・フルダラビンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フルダラビンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・フルダラビンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fludarabine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fludarabine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult accounting for % of the Fludarabine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intravenous segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fludarabine include Sanofi, Bayer, Genzyme, Pfizer, and Salius Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fludarabine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous
Static Drops
Market segment by Application can be divided into
Adult
Children
Pregnant Or Nursing Women
The key market players for global Fludarabine market are listed below:
Sanofi
Bayer
Genzyme
Pfizer
Salius Pharma
Berlex Healthcare
Sagent Pharma
Actavis (TEVA )
Fresenius Kabi
Hospira Healthcare
Leucadia Pharmaceuticals
Mylan Institutional
Shanxi Pude Pharmaceutical
Guangdong Lingnan Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Hainan Jinrui Pharmaceutical
HISUN
Chenxin Pharmaceutical
Chongqing Laimei Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fludarabine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fludarabine, with price, sales, revenue and global market share of Fludarabine from 2019 to 2022.
Chapter 3, the Fludarabine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fludarabine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fludarabine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fludarabine.
Chapter 13, 14, and 15, to describe Fludarabine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Fludarabine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fludarabine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravenous
1.2.3 Static Drops
1.3 Market Analysis by Application
1.3.1 Overview: Global Fludarabine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult
1.3.3 Children
1.3.4 Pregnant Or Nursing Women
1.4 Global Fludarabine Market Size & Forecast
1.4.1 Global Fludarabine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fludarabine Sales in Volume (2017-2028)
1.4.3 Global Fludarabine Price (2017-2028)
1.5 Global Fludarabine Production Capacity Analysis
1.5.1 Global Fludarabine Total Production Capacity (2017-2028)
1.5.2 Global Fludarabine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fludarabine Market Drivers
1.6.2 Fludarabine Market Restraints
1.6.3 Fludarabine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Fludarabine Product and Services
2.1.4 Sanofi Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Fludarabine Product and Services
2.2.4 Bayer Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genzyme
2.3.1 Genzyme Details
2.3.2 Genzyme Major Business
2.3.3 Genzyme Fludarabine Product and Services
2.3.4 Genzyme Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Fludarabine Product and Services
2.4.4 Pfizer Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Salius Pharma
2.5.1 Salius Pharma Details
2.5.2 Salius Pharma Major Business
2.5.3 Salius Pharma Fludarabine Product and Services
2.5.4 Salius Pharma Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Berlex Healthcare
2.6.1 Berlex Healthcare Details
2.6.2 Berlex Healthcare Major Business
2.6.3 Berlex Healthcare Fludarabine Product and Services
2.6.4 Berlex Healthcare Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sagent Pharma
2.7.1 Sagent Pharma Details
2.7.2 Sagent Pharma Major Business
2.7.3 Sagent Pharma Fludarabine Product and Services
2.7.4 Sagent Pharma Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Actavis (TEVA )
2.8.1 Actavis (TEVA ) Details
2.8.2 Actavis (TEVA ) Major Business
2.8.3 Actavis (TEVA ) Fludarabine Product and Services
2.8.4 Actavis (TEVA ) Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fresenius Kabi
2.9.1 Fresenius Kabi Details
2.9.2 Fresenius Kabi Major Business
2.9.3 Fresenius Kabi Fludarabine Product and Services
2.9.4 Fresenius Kabi Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hospira Healthcare
2.10.1 Hospira Healthcare Details
2.10.2 Hospira Healthcare Major Business
2.10.3 Hospira Healthcare Fludarabine Product and Services
2.10.4 Hospira Healthcare Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Leucadia Pharmaceuticals
2.11.1 Leucadia Pharmaceuticals Details
2.11.2 Leucadia Pharmaceuticals Major Business
2.11.3 Leucadia Pharmaceuticals Fludarabine Product and Services
2.11.4 Leucadia Pharmaceuticals Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mylan Institutional
2.12.1 Mylan Institutional Details
2.12.2 Mylan Institutional Major Business
2.12.3 Mylan Institutional Fludarabine Product and Services
2.12.4 Mylan Institutional Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanxi Pude Pharmaceutical
2.13.1 Shanxi Pude Pharmaceutical Details
2.13.2 Shanxi Pude Pharmaceutical Major Business
2.13.3 Shanxi Pude Pharmaceutical Fludarabine Product and Services
2.13.4 Shanxi Pude Pharmaceutical Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Guangdong Lingnan Pharmaceutical
2.14.1 Guangdong Lingnan Pharmaceutical Details
2.14.2 Guangdong Lingnan Pharmaceutical Major Business
2.14.3 Guangdong Lingnan Pharmaceutical Fludarabine Product and Services
2.14.4 Guangdong Lingnan Pharmaceutical Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jiangsu Aosaikang Pharmaceutical
2.15.1 Jiangsu Aosaikang Pharmaceutical Details
2.15.2 Jiangsu Aosaikang Pharmaceutical Major Business
2.15.3 Jiangsu Aosaikang Pharmaceutical Fludarabine Product and Services
2.15.4 Jiangsu Aosaikang Pharmaceutical Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Hainan Jinrui Pharmaceutical
2.16.1 Hainan Jinrui Pharmaceutical Details
2.16.2 Hainan Jinrui Pharmaceutical Major Business
2.16.3 Hainan Jinrui Pharmaceutical Fludarabine Product and Services
2.16.4 Hainan Jinrui Pharmaceutical Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 HISUN
2.17.1 HISUN Details
2.17.2 HISUN Major Business
2.17.3 HISUN Fludarabine Product and Services
2.17.4 HISUN Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Chenxin Pharmaceutical
2.18.1 Chenxin Pharmaceutical Details
2.18.2 Chenxin Pharmaceutical Major Business
2.18.3 Chenxin Pharmaceutical Fludarabine Product and Services
2.18.4 Chenxin Pharmaceutical Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Chongqing Laimei Pharmaceutical
2.19.1 Chongqing Laimei Pharmaceutical Details
2.19.2 Chongqing Laimei Pharmaceutical Major Business
2.19.3 Chongqing Laimei Pharmaceutical Fludarabine Product and Services
2.19.4 Chongqing Laimei Pharmaceutical Fludarabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fludarabine Breakdown Data by Manufacturer
3.1 Global Fludarabine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fludarabine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fludarabine
3.4 Market Concentration Rate
3.4.1 Top 3 Fludarabine Manufacturer Market Share in 2021
3.4.2 Top 6 Fludarabine Manufacturer Market Share in 2021
3.5 Global Fludarabine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fludarabine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fludarabine Market Size by Region
4.1.1 Global Fludarabine Sales in Volume by Region (2017-2028)
4.1.2 Global Fludarabine Revenue by Region (2017-2028)
4.2 North America Fludarabine Revenue (2017-2028)
4.3 Europe Fludarabine Revenue (2017-2028)
4.4 Asia-Pacific Fludarabine Revenue (2017-2028)
4.5 South America Fludarabine Revenue (2017-2028)
4.6 Middle East and Africa Fludarabine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fludarabine Sales in Volume by Type (2017-2028)
5.2 Global Fludarabine Revenue by Type (2017-2028)
5.3 Global Fludarabine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fludarabine Sales in Volume by Application (2017-2028)
6.2 Global Fludarabine Revenue by Application (2017-2028)
6.3 Global Fludarabine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fludarabine Sales by Type (2017-2028)
7.2 North America Fludarabine Sales by Application (2017-2028)
7.3 North America Fludarabine Market Size by Country
7.3.1 North America Fludarabine Sales in Volume by Country (2017-2028)
7.3.2 North America Fludarabine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fludarabine Sales by Type (2017-2028)
8.2 Europe Fludarabine Sales by Application (2017-2028)
8.3 Europe Fludarabine Market Size by Country
8.3.1 Europe Fludarabine Sales in Volume by Country (2017-2028)
8.3.2 Europe Fludarabine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fludarabine Sales by Type (2017-2028)
9.2 Asia-Pacific Fludarabine Sales by Application (2017-2028)
9.3 Asia-Pacific Fludarabine Market Size by Region
9.3.1 Asia-Pacific Fludarabine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fludarabine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fludarabine Sales by Type (2017-2028)
10.2 South America Fludarabine Sales by Application (2017-2028)
10.3 South America Fludarabine Market Size by Country
10.3.1 South America Fludarabine Sales in Volume by Country (2017-2028)
10.3.2 South America Fludarabine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fludarabine Sales by Type (2017-2028)
11.2 Middle East & Africa Fludarabine Sales by Application (2017-2028)
11.3 Middle East & Africa Fludarabine Market Size by Country
11.3.1 Middle East & Africa Fludarabine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fludarabine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fludarabine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fludarabine
12.3 Fludarabine Production Process
12.4 Fludarabine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fludarabine Typical Distributors
13.3 Fludarabine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer